Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Nov 9:15:1-5.
doi: 10.1016/j.jcte.2018.11.001. eCollection 2019 Mar.

Is oxidative stress of adipocytes a cause or a consequence of the metabolic syndrome?

Affiliations
Review

Is oxidative stress of adipocytes a cause or a consequence of the metabolic syndrome?

Leonid N Maslov et al. J Clin Transl Endocrinol. .

Abstract

Metabolic syndrome is accompanied by oxidative stress in animals and humans. The main source of ROS in experimental metabolic syndrome is NADPH oxidase and possibly adipocyte mitochondria. It is now documented that oxidative stress induces insulin resistance of adipocytes and increases secretion of leptin, MCP-1, IL-6, and TNF-α by adipocytes. It was established that oxidative stress induces a decrease in adiponectin production by adipocytes. It has also been shown that obesity itself can induce oxidative stress. Oxidative stress can cause an alteration of intracellular signaling in adipocytes that apparently leads to the formation of insulin resistance of adipocytes. Chronic stress, glucocorticoids, mineralocorticoids, angiotensin-II, TNF-α also play an important role in the pathogenesis of oxidative stress of adipocytes. Oxidative stress is not only a consequence of metabolic syndrome, but also a reason and a foundational link in the pathogenesis of the metabolic syndrome.

Keywords: Adipocytes; Metabolic syndrome; Oxidative stress.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
The relationship of metabolic syndrome and oxidative stress. ROS, reactive oxygen species; SOD, superoxide dismutase; TNF-α, tumor necrosis factor-α.

References

    1. Beck-Nielsen H. Introduction and definition of the metabolic syndrome. In: Beck-Nielsen H., editor. The metabolic syndrome: pharmacology and clinical aspects. Springer-Verlag; Wien: 2013. pp. 1–6.
    1. Aguilar M., Bhuket T., Torres S., Liu B., Wong R.J. Prevalence of the metabolic syndrome in the United States, 2003–2012. JAMA. 2015;313(19):1973–1974. - PubMed
    1. Block A., Schipf S., Van der Auwera S., Hannemann A., Nauck M., John U. Sex- and age-specific associations between major depressive disorder and metabolic syndrome in two general population samples in Germany. Nord J Psychiatry. 2016;70(8):611–620. - PubMed
    1. Mitrofanov I.M., Seliatitskaia V.G., Nikolaev IuA, Lutov IuV. The prevalence of metabolic syndrome in an organized population. Klin Med (Mosk) 2012;90(11):47–50. - PubMed
    1. Isomaa B., Almgren P., Tuomi T., Forsén B., Lahti K., Nissén M. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diab Care. 2001;24(4):683–689. - PubMed